(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
'Dancing with the Stars' semifinals: How to watch Episode 10 tonight, where to stream, who's left and more - 2I watched the buzzy new AI documentary — and left feeling both hopeful and terrified
- 321 Incredibly Interesting Contemplations To Observe Consistently
- 4Former Peruvian President Pedro Castillo sentenced for conspiracy
- 5'Women on the floor, riddled with bullets': Ex-hostage Rom Braslavski recounts 'horrors' of Oct. 7
- Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- Eight wounded, cars catch fire in central Israel following strike from Iranian cluster munition
- Surge of off‑lease electric vehicles expected to drive down used EV prices
- Authorities Bust Camel Booze Smuggling Operation, Seize Nearly 2,000 Containers of Illegal Alcohol
- What will the Artemis 2 astronauts eat during their historic moon mission? (video)
- Health officials report 14 Legionnaires' disease cases in Florida, gym connection suspected
- Figure out How to Alter Your Volvo XC40 for Further developed Solace
- Ancient Egyptian pharaoh's boat is being reassembled in public at the Grand Egyptian Museum
- Brazil Passes Law to Use Seized Bitcoin, Crypto to Fund Public Security Measures
